HR97 (TFA)

HR97 TFA is a cell-penetrating peptide that can be combined with engineered melanin to prepare eye drops HR97-SunitiGel. The peptide-drug conjugate in HR97-SunitiGel can provide sustained ocular drug delivery[1].

Product Specifications

UNSPSC

12352209

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Others

Purity

98.91

Smiles

O=C(N[C@@H](CO)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N1[C@@H](CCC1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CS)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=CC=C2)N.O=C(C(F)(F)F)O.[x]

Molecular Formula

C64H115N27O14S.xC2HF3O2

Molecular Weight

1518.84 (free acid)

References & Citations

[1]Hsueh HT, et al. Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats. J Control Release. 2023 Oct;362:371-380.